28 May 2017 - 18:56
Get paid $400 to be in this study.
This study builds on our discovery that a potent NMDA receptor antagonist, ketamine, has rapid (hours) and robust therapeutic effects in OCD and will help us understand how ketamine works to relieve repetitive thoughts and behaviours.
Purpose: To understand how new drug brings about rapid improvement in OCD symptoms.
This clinical study is funded by the by the National Institute of Mental Health (NIMH) and is listed in clinicaltrials.gov.